What should you know about lung melanoma?

Melanoma usually begins in pigment-producing cells, most often in the skin. When a scan shows a suspicious lung lesion, specialists consider whether it is a melanoma that began there or a spread from a skin, eye or other melanoma. Imaging cannot settle that question on its own. A biopsy lets a laboratory examine cells and may include tests that help identify the tumour type.

The team may review the skin, lymph nodes and other organs, because the extent and location of disease affect the plan. A lung lesion can also have causes unrelated to melanoma, so avoid interpreting the scan before the clinical team explains it.

Arrange prompt review with the clinician who ordered the scan. Bring previous imaging, pathology reports and a list of medicines. The work-up may include chest imaging, a biopsy, laboratory testing and staging scans. Treatment can involve surgery when the tumour can be removed, systemic treatment such as immunotherapy, or a combination chosen by a multidisciplinary team.

Ask how the biopsy will be obtained and when results are expected. If melanoma began elsewhere, care may be coordinated with a skin-cancer or oncology service. Follow-up after treatment is used to watch for change and manage treatment effects.

Seek emergency help for severe or rapidly worsening breathlessness, coughing blood, blue or grey lips, confusion, fainting, or chest pain with sweating or weakness. Contact your treating team promptly for new persistent cough, worsening pain, unexplained weakness, severe headache or a change in vision, particularly during cancer treatment.

Ask whether the lesion appears to have started in the lung or represents spread, what biopsy is recommended, which scans are needed for staging, and how treatment choices fit your overall health. Clarify who will coordinate follow-up and which symptoms should trigger an urgent call.